Search

everythinglearnresearchcommunity

for

Search:↓

Surgical excision is the best treatment for SCC, but intralesional cidofovir might be a good alternative.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Composite biomaterials can precisely control immune responses for better disease treatment.

Both VEPA and ML-Y1 treatments are not effective enough for elderly non-Hodgkin's lymphoma patients.

Taxane-based chemotherapy causes more hair loss and skin changes in Asian breast cancer patients.

A new method helps manage skin side effects from hormonal cancer therapy, improving patient care.

An elderly woman's upper lip lump, thought to be a mucocele, was actually a rare type of lymphoma usually found on legs, treated successfully with chemotherapy and radiation.

Combined therapy reduces inflammation and restores immune balance in alopecia areata patients.

Repurposing existing drugs can improve cancer treatment but faces challenges.

Chemotherapy in children often causes hair loss, nausea, vomiting, and mood swings.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Green-synthesized nanoparticles can effectively target cancer cells, reducing side effects and improving treatment.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Co-trimoxazole may help treat autoimmune diseases.

Cancer prevention has progressed with successful drugs and vaccines, but challenges remain in understanding genetic changes and improving strategies.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

The treatment was effective and tolerable for advanced gastric cancer.

Permanent hair loss from chemotherapy significantly impacts patients' mental health and social life, highlighting the need for better patient education and support.

Many drugs, not just chemotherapy, can cause reversible hair loss.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

JAK/STAT1 pathway causes hair loss during chemotherapy by reducing Shh in hair follicles.

Patients prefer non-drug methods like massage and music to manage chemotherapy side effects, but standardization is needed.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

Cetuximab can cause unusual hair growth and hair loss.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.